Holen Sie sich die Stockscreener-App
2.01
2.03%
0.04
Handel nachbörslich:
2.02
0.01
+0.50%
Schlusskurs vom Vortag:
$1.97
Offen:
$1.97
24-Stunden-Volumen:
241.13K
Relative Volume:
0.44
Marktkapitalisierung:
$127.09M
Einnahmen:
$4.39M
Nettoeinkommen (Verlust:
$-22.40M
KGV:
-3.9427
EPS:
-0.5098
Netto-Cashflow:
$-22.79M
1W Leistung:
+14.86%
1M Leistung:
+13.56%
6M Leistung:
+34.00%
1J Leistung:
+325.22%
1-Tages-Spanne:
$1.97
$2.10
1-Wochen-Bereich:
$1.76
$2.15
52-Wochen-Spanne:
$0.27
$2.70
Equillium Inc Stock (EQ) Company Profile
Firmenname
Equillium Inc
Sektor
Branche
Telefon
(858) 412-5302
Adresse
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Compare EQ vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EQ
Equillium Inc
|
2.01 | 124.56M | 4.39M | -22.40M | -22.79M | -0.5098 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-13 | Eingeleitet | Roth Capital | Buy |
| 2026-02-25 | Eingeleitet | Stifel | Buy |
| 2025-03-28 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2021-10-29 | Fortgesetzt | Stifel | Buy |
| 2021-09-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-07-14 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-10 | Fortgesetzt | Stifel | Buy |
| 2019-02-22 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Equillium Inc Aktie (EQ) Neueste Nachrichten
Breakout Watch: What is the target price for Equillium Inc stock2026 Technical Overview & Precise Swing Trade Alerts - baoquankhu1.vn
Equillium (EQ) price target increased by 120.00% to 5.61 - MSN
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sahm
Equillium reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - tradingview.com
Reverse split range 1-for-2–1-for-20; Equillium (NASDAQ: EQ) seeks 400M cap - Stock Titan
Operating cash flow per share of Equillium, Inc. – LSX:A2N7B3 - TradingView
Cash per share of Equillium, Inc. – LSX:A2N7B3 - TradingView
Equillium Inc. 2025 Financial Review - AlphaStreet
EQUILLIUM ($EQ) Releases Q4 2025 Earnings - Moomoo
[EFFECT] Equillium, Inc. SEC Filing - stocktitan.net
Equillium 2025 10-K: Advancing EQ504 AhR Modulator for Autoimmune & Inflammatory Disease Therapies - Minichart
RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in Equillium Inc - GuruFocus
Equillium Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Equillium Inc. (NASDAQ:EQ) Reports In-Line Q4 Earnings, Highlights Pipeline Progress and Runway into 2029 - ChartMill
Equillium (EQ) Secures Financial Path to 2029, Focuses on Key Dr - GuruFocus
Equillium reports lower-than-expected Q4 net loss - TradingView
Equillium (NASDAQ:EQ) Announces Quarterly Earnings Results - MarketBeat
Equillium (NASDAQ: EQ) expands autoimmune pipeline and raises $65M in private financings - stocktitan.net
Equillium, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Equillium (EQ) shifts to EQ504 focus, raises $85M and funds into 2029 - Stock Titan
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights - globenewswire.com
Here’s What Roth Capital Thinks of Equillium (EQ) Stock - Insider Monkey
Equillium Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
RA Capital group reports 9.9% stake in EQ (NASDAQ: EQ) via warrants - Stock Titan
Macro Review: What is the target price for Equillium Inc stock2026 Earnings Impact & Daily Profit Focused Screening - baoquankhu1.vn
Equillium (EQ) Expected to Announce Earnings on Thursday - MarketBeat
Equillium, Inc. Hits New 52-Week High of $2.62, Up 249% - Markets Mojo
Equillium to Participate in the 38th Annual Roth Conference - Bitget
Risk Recap: Can Equillium Inc reach all time highs this year2026 Intraday Action & Expert Approved Momentum Ideas - baoquankhu1.vn
Equillium, Inc. Hits New 52-Week High of $2.70, Up 228% Yearly - Markets Mojo
Equillium (NASDAQ:EQ) COO Sells $300,780.00 in Stock - MarketBeat
Equillium (EQ) SVP Zedelmayer sells $300k in shares By Investing.com - Investing.com Australia
Equillium (EQ) SVP Zedelmayer sells $300k in shares - Investing.com
Equillium (EQ) COO exercises options and sells 120,312 shares under plan - Stock Titan
This analyst loves Equillium - Cantech Letter
Cantor Fitzgerald L. P. Invests $608,000 in Equillium, Inc. $EQ - MarketBeat
Equillium Strengthens Financial Position with New Investments - StocksToTrade
Equillium: $35 Million Raised For Biotech Therapy Development - Pulse 2.0
Equillium (NASDAQ:EQ) Coverage Initiated at Roth Mkm - Defense World
Analysts Are Bullish on Top Healthcare Stocks: Equillium (EQ), Qiagen (QGEN) - The Globe and Mail
Equillium (NASDAQ:EQ) Raised to "Hold" at Wall Street Zen - MarketBeat
Equillium secures $35M financing from RA Capital Management By Investing.com - Investing.com South Africa
Equillium secures $35M financing from RA Capital Management - Investing.com Australia
Proposed resale of 120,312 EQ shares reported (EQ) - Stock Titan
EQ SEC FilingsEquillium 10-K, 10-Q, 8-K Forms - Stock Titan
Equillium (EQ) Secures $35 Million Through RA Capital Management Investment - GuruFocus
Equillium (EQ) Receives Buy Rating from Roth Capital | EQ Stock News - GuruFocus
Roth Mkm Initiates Coverage on Equillium (NASDAQ:EQ) - MarketBeat
Equillium, Inc. (NASDAQ:EQ) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Equillium Raises Capital Through Private Equity Securities Sale - TipRanks
Finanzdaten der Equillium Inc-Aktie (EQ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):